Krebs Biochemicals & Industries Ltd Share Price
Last Updated Date: 21 Sept 2026
₹56.13
-1.03 (-1.80%)
As of 21 Sept 2026, Krebs Biochemicals & Industries Ltd share price is ₹56.13. The stock opened at ₹56.13 and had closed at ₹57.16 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹38.52 and a high of ₹81.80. In terms of performance, Krebs Biochemicals & Industries Ltd share price has increased by 21.28% over the past six months and has decreased by 29.43% over the last year.
KREBSBIO Stock Price Chart
Krebs Biochemicals & Industries Ltd Overview
Market cap₹123 Crs
Volume2,591
Prev. Close₹57.16
Year range₹38.52 - ₹81.80
ISININE268B01013
About KREBSBIO
Krebs Biochemicals & Industries is engaged in the business of manufacture of active pharmaceutical ingredients.
Krebs Biochemicals & Industries Ltd Historical Performance
1 Month Return2.42%
6 Month Return16.37%
3 Year Return-12.06%
3 Month Return-11.74%
1 Year Return-26.87%
5 Year Return-70.66%
Krebs Biochemicals & Industries Ltd Fundamentals
ROCE(TTM)-9.06%
P/E Ratio (TTM)-8.74
P/B Ratio0.00
Debt to Equity-1.38
ROE10.40%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value-75.49
Profit Margin-55.85%
Operating Margin-35.47%
Krebs Biochemicals & Industries Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 25.76 | 44.02 | 50.87 | 52.75 | 60.86 |
| EBITDA | -3.42 | -14.32 | -8.27 | -15.16 | -32.84 |
| Net Profit | -16.93 | -26.94 | -19.73 | -24.69 | -44.53 |
| EPS | -7.85 | -12.49 | -9.16 | -11.30 | -20.81 |
Krebs Biochemicals & Industries Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 54.99 |
| Resistance 1 (R1) | 60.40 |
| Pivot Point | 58.22 |
KREBSBIO Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| R T Ravi | Chairman |
| Pabitra Bhattacharya | Managing Director |
| Avinash Ravi | Non Executive Independent Director |
Krebs Biochemicals & Industries Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,873.50+1.97% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,443.50+0.73% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,964.00+2.56% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Krebs Biochemicals & Industries Ltd today is ₹56.13 on NSE and ₹56.13 on BSE.
- The 52-week high of Krebs Biochemicals & Industries Ltd is ₹81.80, while the 52-week low is ₹38.52.
- The current market capitalisation of Krebs Biochemicals & Industries Ltd is approximately ₹123 crore.
- The P/E (Price-to-Earnings) ratio of Krebs Biochemicals & Industries Ltd is -8.74. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Krebs Biochemicals & Industries Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Krebs Biochemicals & Industries Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for KREBSBIO on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Krebs Biochemicals & Industries Ltd has delivered a return of approximately -12.06%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Krebs Biochemicals & Industries Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 72.74% promoters, 0.50% FIIs, 0.00% DIIs, and 19.67% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
